Company: DHR
Filing Date: 2025-07-22
Form Type: 10-Q
Source: 0000313616-25-000153
Chunk: 75

Company: DANAHER CORP /DE/
Filing Date: 2025-07-22
Form: 10-Q
Item: Item 8
Chunk 75
---
8 million and 1.7 million options, respectively, to purchase shares were excluded from the diluted EPS calculation, as the impact of their inclusion would have been anti-dilutive.  Basic and diluted EPS are computed independently for each quarter and year-to-date period, and each period involves the use of different weighted average share count figures.  As a result, and after factoring in the effect of rounding to the nearest cent per share, the sum of prior quarterly EPS figures may not equal year-to-date EPS.

7

Information related to the calculation of net earnings per common share is summarized as follows ($ and shares in millions, except per share amounts):Three-Month Period EndedSix-Month Period EndedJune 27, 2025June 28, 2024June 27, 2025June 28, 2024Numerator:Net earnings $555 $907 $1,509 $1,995 Denominator:Weighted average common shares outstanding used in Basic EPS716.5 737.6 716.4 739.1 Incremental common shares from:Assumed exercise of dilutive options and vesting of dilutive restricted stock units (“RSUs”) and performance stock units (“PSUs”)2.6 4.8 3.5 6.4 Weighted average common shares outstanding used in Diluted EPS719.1 742.4 719.9 745.5 Basic EPS $0.77 $1.23 $2.11 $2.70 Diluted EPS $0.77 $1.22 $2.10 $2.68 

NOTE 4.  REVENUE

The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and six-month periods ended June 27, 2025 and June 28, 2024 ($ in millions).  Sales taxes and other usage-based taxes collected from customers are excluded from revenue.BiotechnologyLife SciencesDiagnosticsTotalFor the Three-Month Period Ended June 27, 2025:Geographical region:North America(a)$612 $762 $1,064 $2,438 Western Europe708 394 405 1,507 Other developed markets(b)82 118 94 294 High-growth markets(c)448 503 746 1,697 Total$1,850 $1,777 $2,